Latest news
Pacific Biosciences of California, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PACB) 2026-08-08 - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 23:13:40 GMTPacific Biosciences of California Inc (HAM:P09) Stock Price, Trades & News - GuruFocusGuruFocus · Sat, 08 Aug 2026 18:03:12 GMTEarnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:41:26 GMTPACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook - StockStoryStockStory · Thu, 06 Aug 2026 22:58:55 GMTPACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:50:20 GMTPacific Biosciences of California, Inc. Stock 12‑Month Price Target Cut to $2.29, Implies 76% Upside - TradingViewTradingView · Thu, 06 Aug 2026 20:24:18 GMTTD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3 - MoomooMoomoo · Thu, 06 Aug 2026 18:22:07 GMTPacBio CEO steps down amid layoffs, widening Q2 loss - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 14:45:21 GMT